|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DiMagno EP, Reber HA and Tempero MA;
American Gastroenterological Association. AGA technical review on
the epidemiology, diagnosis, and treatment of pancreatic ductal
adenocarcinoma. Gastroenterology. 117:1464–1484. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ellenrieder V, Adler G and Gress TM:
Invasion and metastasis in pancreatic cancer. Ann Oncol. 10(Suppl
4): S46–S50. 1999. View Article : Google Scholar
|
|
4
|
Boucheix C, Duc GH, Jasmin C and
Rubinstein E: Tetraspanins and malignancy. Expert Rev Mol Med.
2001:1–17. 2001.
|
|
5
|
Zöller M: Tetraspanins: Push and pull in
suppressing and promoting metastasis. Nat Rev Cancer. 9:40–55.
2009. View
Article : Google Scholar
|
|
6
|
Kanetaka K, Sakamoto M, Yamamoto Y,
Takamura M, Kanematsu T and Hirohashi S: Possible involvement of
tetraspanin CO-029 in hematogenous intrahepatic metastasis of liver
cancer cells. J Gastroenterol Hepatol. 18:1309–1314. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ruseva Z, Geiger PX, Hutzler P, Kotzsch M,
Luber B, Schmitt M, Gross E and Reuning U: Tumor suppressor KAI1
affects integrin alphavbeta3-mediated ovarian cancer cell adhesion,
motility, and proliferation. Exp Cell Res. 315:1759–1771. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Longo N, Yáñez-Mó M, Mittelbrunn M, de la
Rosa G, Muñoz ML, Sánchez-Madrid F and Sánchez-Mateos P: Regulatory
role of tetraspanin CD9 in tumor-endothelial cell interaction
during transendothelial invasion of melanoma cells. Blood.
98:3717–3726. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Novitskaya V, Romanska H, Dawoud M, Jones
JL and Berditchevski F: Tetraspanin CD151 regulates growth of
mammary epithelial cells in three-dimensional extracellular matrix:
Implication for mammary ductal carcinoma in situ. Cancer Res.
70:4698–4708. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Adachi M, Taki T, Ieki Y, Huang CL,
Higashiyama M and Miyake M: Correlation of KAI1/CD82 gene
expression with good prognosis in patients with non-small cell lung
cancer. Cancer Res. 56:1751–1755. 1996.PubMed/NCBI
|
|
11
|
Nakamoto T, Murayama Y, Oritani K,
Boucheix C, Rubinstein E, Nishida M, Katsube F, Watabe K, Kiso S,
Tsutsui S, et al: A novel therapeutic strategy with anti-CD9
antibody in gastric cancers. J Gastroenterol. 44:889–896. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Marken JS, Schieven GL, Hellström I,
Hellström KE and Aruffo A: Cloning and expression of the
tumor-associated antigen L6. Proc Natl Acad Sci USA. 89:3503–3507.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maecker HT, Todd SC and Levy S: The
tetraspanin superfamily: molecular facilitators. FASEB J.
11:428–442. 1997.PubMed/NCBI
|
|
14
|
Kao YR, Shih JY, Wen WC, Ko YP, Chen BM,
Chan YL, Chu YW, Yang PC, Wu CW and Roffler SR: Tumor-associated
antigen L6 and the invasion of human lung cancer cells. Clin Cancer
Res. 9:2807–2816. 2003.PubMed/NCBI
|
|
15
|
Allioli N, Vincent S, Vlaeminck-Guillem V,
Decaussin-Petrucci M, Ragage F, Ruffion A and Samarut J: TM4SF1, a
novel primary androgen receptor target gene over-expressed in human
prostate cancer and involved in cell migration. Prostate.
71:1239–1250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gordon GJ, Jensen RV, Hsiao LL, Gullans
SR, Blumenstock JE, Richards WG, Jaklitsch MT, Sugarbaker DJ and
Bueno R: Using gene expression ratios to predict outcome among
patients with mesothelioma. J Natl Cancer Inst. 95:598–605. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abba MC, Drake JA, Hawkins KA, Hu Y, Sun
H, Notcovich C, Gaddis S, Sahin A, Baggerly K and Aldaz CM:
Transcriptomic changes in human breast cancer progression as
determined by serial analysis of gene expression. Breast Cancer
Res. 6:R499–R513. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zukauskas A, Merley A, Li D, Ang LH,
Sciuto TE, Salman S, Dvorak AM, Dvorak HF and Jaminet SC: TM4SF1: A
tetraspanin-like protein necessary for nanopodia formation and
endothelial cell migration. Angiogenesis. 14:345–354. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shih SC, Zukauskas A, Li D, Liu G, Ang LH,
Nagy JA, Brown LF and Dvorak HF: The L6 protein TM4SF1 is critical
for endothelial cell function and tumor angiogenesis. Cancer Res.
69:3272–3277. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ohuchida K, Mizumoto K, Murakami M, Qian
LW, Sato N, Nagai E, Matsumoto K, Nakamura T and Tanaka M:
Radiation to stromal fibroblasts increases invasiveness of
pancreatic cancer cells through tumor-stromal interactions. Cancer
Res. 64:3215–3222. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hruban RH, Klöppel G, Boffetta P, et al:
Ductal adenocarcinoma of the pancreas. WHO Classification of
Tumours of the Digestive System. World Health Organization; pp.
281–291. 2010
|
|
22
|
Edge SB, Byrd DR, Compton CC, et al:
Exocrine and Endocrine Pancreas, AJCC Cancer Staging Manual. 7th
edition. Springer; New York, NY: pp. 241–248. 2010
|
|
23
|
Cui L, Ohuchida K, Mizumoto K, Moriyama T,
Onimaru M, Nakata K, Nabae T, Ueki T, Sato N, Tominaga Y, et al:
Prospectively isolated cancer-associated CD10 (+) fibroblasts have
stronger interactions with CD133 (+) colon cancer cells than with
CD133 (−) cancer cells. PLoS One. 5:e121212010. View Article : Google Scholar
|
|
24
|
Ikenaga N, Ohuchida K, Mizumoto K, Cui L,
Kayashima T, Morimatsu K, Moriyama T, Nakata K, Fujita H and Tanaka
M: CD10+ pancreatic stellate cells enhance the
progression of pancreatic cancer. Gastroenterology. 139:1041–1051.
51 e1–8. 2010. View Article : Google Scholar
|
|
25
|
Moriyama T, Ohuchida K, Mizumoto K, Cui L,
Ikenaga N, Sato N and Tanaka M: Enhanced cell migration and
invasion of CD133+ pancreatic cancer cells cocultured
with pancreatic stromal cells. Cancer. 116:3357–3368. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iwamoto Y, Tanaka K, Okuyama K, Sugioka Y
and Taniguchi S: In vitro assay of the invasive potential of
malignant bone and soft tissue tumours through basement membranes.
Int Orthop. 18:240–247. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ikenaga N, Ohuchida K, Mizumoto K, Akagawa
S, Fujiwara K, Eguchi D, Kozono S, Ohtsuka T, Takahata S and Tanaka
M: Pancreatic cancer cells enhance the ability of collagen
internalization during epithelial-mesenchymal transition. PLoS One.
7:e404342012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kozono S, Ohuchida K, Eguchi D, Ikenaga N,
Fujiwara K, Cui L, Mizumoto K and Tanaka M: Pirfenidone inhibits
pancreatic cancer desmoplasia by regulating stellate cells. Cancer
Res. 73:2345–2356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moustakas A and Heldin CH: Induction of
epithelial-mesenchymal transition by transforming growth factor β.
Semin Cancer Biol. 22:446–454. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lou C, Zhang F, Yang M, Zhao J, Zeng W,
Fang X, Zhang Y, Zhang C and Liang W: Naringenin decreases
invasiveness and metastasis by inhibiting TGF-β-induced epithelial
to mesenchymal transition in pancreatic cancer cells. PLoS One.
7:e509562012. View Article : Google Scholar
|
|
32
|
Svensson HP, Frank IS, Berry KK and Senter
PD: Therapeutic effects of monoclonal antibody-beta-lactamase
conjugates in combination with a nitrogen mustard anticancer
prodrug in models of human renal cell carcinoma. J Med Chem.
41:1507–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tu SH, Huang HI, Lin SI, Liu HY, Sher YP,
Chiang SK, Chong P, Roffler S, Tseng GC, Chen HW, et al: A novel
HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can
inhibit tumor growth in vivo. J Immunother. 35:235–244. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schiedeck TH, Wellm C, Roblick UJ, Broll R
and Bruch HP: Diagnosis and monitoring of colorectal cancer by L6
blood serum polymerase chain reaction is superior to
carcinoembryonic antigen-enzyme-linked immunosorbent assay. Dis
Colon Rectum. 46:818–825. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bringuier PP, Umbas R, Schaafsma HE,
Karthaus HF, Debruyne FM and Schalken JA: Decreased E-cadherin
immunoreactivity correlates with poor survival in patients with
bladder tumors. Cancer Res. 53:3241–3245. 1993.PubMed/NCBI
|
|
37
|
Endo K, Ueda T, Ueyama J, Ohta T and
Terada T: Immunoreactive E-cadherin, alpha-catenin, beta-catenin,
and gamma-catenin proteins in hepatocellular carcinoma:
Relationships with tumor grade, clinicopathologic parameters, and
patients’ survival. Hum Pathol. 31:558–565. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shimamura T, Sakamoto M, Ino Y, Sato Y,
Shimada K, Kosuge T, Sekihara H and Hirohashi S: Dysadherin
overexpression in pancreatic ductal adenocarcinoma reflects tumor
aggressiveness: Relationship to e-cadherin expression. J Clin
Oncol. 21:659–667. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hemler ME: Tetraspanin proteins mediate
cellular penetration, invasion, and fusion events and define a
novel type of membrane microdomain. Annu Rev Cell Dev Biol.
19:397–422. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Berditchevski F: Complexes of tetraspanins
with integrins: More than meets the eye. J Cell Sci. 114:4143–4151.
2001.PubMed/NCBI
|
|
41
|
Sterk LM, Geuijen CA, Oomen LC, Calafat J,
Janssen H and Sonnenberg A: The tetraspan molecule CD151, a novel
constituent of hemidesmosomes, associates with the integrin
alpha6beta4 and may regulate the spatial organization of
hemidesmosomes. J Cell Biol. 149:969–982. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Testa JE, Brooks PC, Lin JM and Quigley
JP: Eukaryotic expression cloning with an antimetastatic monoclonal
antibody identifies a tetraspanin (PETA-3/CD151) as an effector of
human tumor cell migration and metastasis. Cancer Res.
59:3812–3820. 1999.PubMed/NCBI
|
|
43
|
Lekishvili T, Fromm E, Mujoomdar M and
Berditchevski F: The tumour-associated antigen L6 (L6-Ag) is
recruited to the tetraspanin-enriched microdomains: Implication for
tumour cell motility. J Cell Sci. 121:685–694. 2008. View Article : Google Scholar : PubMed/NCBI
|
